Targeting NF-κB signaling in astrocytes to alleviate neurodegeneration may be more broadly applicable: the lifespan of flies expressing Aβ peptides, present in patients with AD, was extended upon astrocyte-specific inhibition of NF-κB (Fig. 5e). Here, NFKB1 is linked to Alzheimer disease.